Literature DB >> 22367728

Sporadic endolymphatic sac tumor: its clinical, radiological, and histological features, management, and follow-up.

Arturo M Poletti1, Siba P Dubey, Regina Barbò, Sergio Pericotti, Barbara Fiamengo, Giovanni Colombo, Marta Scorsetti, Rosaria Lorusso, Antonio Mazzoni.   

Abstract

BACKGROUND: Sporadic endolymphatic sac tumor (ELST) is rare. We described the clinical, radiological, and histological features, treatment, and follow-up of ELST.
METHOD: This was a retrospective analysis of 7 cases of sporadic ELST that were managed between 1993 and 2010.
RESULTS: Twenty-five to 75 years was the age range of the patients. Subjective hearing loss and tinnitus were the most common presenting features. Five patients had total deafness and 2 had severe sensorineural hearing loss. The most common radiological feature was temporal bone destruction with tumor extension to cerebellopontine angle and posterior cranial fossa. Cholesterol or hemosiderin cysts around the tumor could be a characteristic feature. Major skull base procedures were performed in all 7 cases, and complete tumor excision was achieved in 6 of them. One patient needed a second surgery after she was referred to us after an incomplete first surgery. Recurrences were detected in 2 patients during follow-up; 1 of them received irradiation without minimal change to the tumor size and the second refused any treatment for the recurrence. Both of them are alive with disease.
CONCLUSION: Early detection and radical surgical excision at first attempt give best results. Radiotherapy could be considered only in unresectable recurrences.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22367728     DOI: 10.1002/hed.22962

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  7 in total

1.  Clinicoradiologic characteristics of endolymphatic sac tumors.

Authors:  Hongbo Le; Huihong Zhang; Weijing Tao; Lan Lin; Jie Li; Lin Ma; Guobin Hong; Xin Lou
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-06-13       Impact factor: 2.503

2.  Treatment of endolymphatic sac tumour (Papillary adenocarcinoma) of the temporal bone.

Authors:  Arturo Mario Poletti; Siba Prasad Dubey; Giovanni Colombo; Giovanni Cugini; Antonio Mazzoni
Journal:  Rep Pract Oncol Radiother       Date:  2015-07-30

Review 3.  Von Hippel-Lindau disease.

Authors:  Prashant Chittiboina; Russell R Lonser
Journal:  Handb Clin Neurol       Date:  2015

4.  An endolymphatic sac tumor with imaging features of aneurysmal bone cysts: differential diagnostic considerations.

Authors:  Bálint Alkonyi; Thomas Günthner-Lengsfeld; Kristen Rak; Johannes Nowak; László Solymosi; Rudolf Hagen
Journal:  Childs Nerv Syst       Date:  2014-06-01       Impact factor: 1.475

5.  Endolymphatic sac tumour in von Hippel-Lindau disease: management strategies.

Authors:  E Zanoletti; L Girasoli; D Borsetto; G Opocher; A Mazzoni; A Martini
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-10       Impact factor: 2.124

6.  Clinical response to pazopanib in a patient with endolymphatic sac tumor not associated with von Hippel-Lindau syndrome.

Authors:  Thomas Nelson; Jethro Hu; Serguei Bannykh; Xuemo Fan; Jeremy Rudnick; Eric Vail
Journal:  CNS Oncol       Date:  2020-03-06

7.  Transcanal endoscopic assisted skull base endolymphatic sac tumor resection: A rare disease with advanced technology.

Authors:  Wai Tsz Chang; Ka Yue Tam; Hung Yao; Kwan Ho Chow; Michael Chi Fai Tong
Journal:  J Otol       Date:  2019-07-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.